Respiatory Viral Infections in Patients with Multiple Myeloma

Incidence and Clinical Significance of Respiratory Viral Infections in Patients with Multiple Myeloma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06810115

Enrollment

219

Registered

2025-02-05

Start date

2015-10-01

Completion date

2024-10-01

Last updated

2025-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Mieloma, Respiratory Viral Infections

Keywords

Respiratory viral infections

Brief summary

Respiratory viruses are known to be a major cause of morbodity in multiple myeloma patients but prospective long-term sudies are lacking. We analysed 219 multiple myeloma patients that had 554 nasopharingeal swabs with 58 documented viral episodes. Respiratory viruses studied were rhinovirus, enterovirus, parainflienza, respirator, syncytial virus, metapneumovirus, coronavirus, bocavirus, influenza A, influenza B. Clinical data were extracted from a prospectively entered database, medical records were reviewed. We have prospectively studiend patients until May 2019 when we gathered survival data. Lastly because of Covid-19 pandemic when almost no other viral infections were isolated, we analysed clinical course of respiratory infections in patients with multiple myeloma after the pandemic.

Interventions

OTHERViral PCR test

Viral PCR test regardles of symptoms

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with multiple myeloma

Exclusion criteria

Other hematological malignancies \-

Design outcomes

Primary

Measure	Time frame
Number of respiratory viral infections in patirnts with multiple myeloma	1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026